ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )
Clinical trial NCT03938545 · TERMINATED
Trial details
- NCT number
- NCT03938545
- Sponsor
- Immunovant Sciences GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-23
- Primary completion
- 2021-02-02
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.